SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-011142
Filing Date
2021-05-06
Accepted
2021-05-06 16:11:20
Documents
88
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20210331_10q.htm 10-Q 861637
2 EXHIBIT 10.1 ex_245260.htm EX-10.1 48571
3 EXHIBIT 10.2 ex_245261.htm EX-10.2 42416
4 EXHIBIT 10.3 ex_245262.htm EX-10.3 16586
5 EXHIBIT 31.1 ex_243937.htm EX-31.1 10061
6 EXHIBIT 31.2 ex_243938.htm EX-31.2 9049
7 EXHIBIT 32.1 ex_243939.htm EX-32.1 5323
8 EXHIBIT 32.2 ex_243940.htm EX-32.2 4622
  Complete submission text file 0001437749-21-011142.txt   6482564

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT nby-20210331.xml EX-101.INS 1309467
10 XBRL TAXONOMY EXTENSION SCHEMA nby-20210331.xsd EX-101.SCH 89047
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20210331_cal.xml EX-101.CAL 46649
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20210331_def.xml EX-101.DEF 519222
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20210331_lab.xml EX-101.LAB 428489
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20210331_pre.xml EX-101.PRE 551420
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 21897857
SIC: 2834 Pharmaceutical Preparations